-
Marketing: big data -- the sharp tool of paint marketing
Time of Update: 2020-04-03
Core tip: Recently, the International Conference on "big data and official statistics" jointly sponsored by the National Bureau of statistics of China and the United Nations
-
After Fujian and Hebei, another province clearly began to purchase with volume
Time of Update: 2019-08-20
[industry trends of pharmaceutical network] on August 19, Qinghai currently announced the implementation plan for centralized procurement and use of drugs in 2019 in Qinghai
-
Volume purchasing brings a development opportunity and affects many large enterprises
Time of Update: 2019-08-16
[industry trends of pharmaceutical network] recently, relevant departments have deployed the pilot of "4 + 7" volume procurement nationwide, requiring regions not implemented
-
"National auxiliary drug catalog" officially announced! Fly or tiger
Time of Update: 2019-07-03
On July 1, the national health and Health Commission issued the notice on printing and distributing the first batch of national key monitoring and rational drug use catalogue
-
Core technologies to be broken through in the fierce competition of biomedical Market
Time of Update: 2019-03-18
Therefore, mastering the core technology will become the key to promote the development of China's biomedical industry.
-
Song Ruilin: five views on the national drug volume purchase
Time of Update: 2018-11-27
On November 15, the state officially released the full text of "4 + 7" urban drug centralized procurement document
According to the documents, the pilot areas
-
Perspective of industrial development opportunities from policy big data
Time of Update: 2017-11-10
Source: pharmaceutical economic news 2017-11-10 "what kind of market is China's pharmaceutical market? Various reforms have been accompanied by the development of China's
-
Unscramble the new edition of the medical insurance catalogue of traditional Chinese medicine and high sex price medicine to become the new favorite of the market
Time of Update: 2017-03-02
The policy reflects a clear signal that proprietary Chinese medicine and high cost-effective drugs may be the direction of R & D, production and market development of pharmaceutical enterprises in the future.
-
CFDA plans to quickly approve the clinical research application of anti-tumor innovative drugs in 60 days
Time of Update: 2015-08-31
Recently, a source revealed that China's CFDA is considering taking anti-tumor drugs as a pilot and implementing the policy of rapid approval of new clinical trial drugs (ind) within 60 days.
-
Let "charity giving medicine" pave the way for market access
Time of Update: 2015-04-10
From this point of view, the charity drug donation plan is helpful for pharmaceutical companies to achieve market access and obtain medical insurance reimbursement in some specific varieties.
-
How to solve the dilemma of drug standardization
Time of Update: 2013-09-09
Zhang Wei said that for a long time, the leading role in the improvement of drug standards in China has been the government departments, while enterprises are unwilling to take the initiative to participate in it, only passively implement it.
-
How to solve the dilemma of medical standardization? Strengthening the main body of enterprises is the key
Time of Update: 2013-08-31
Zhang Wei said that for a long time, the leading role in the improvement of drug standards in China has been the government departments, while enterprises are unwilling to take the initiative to participate in it, only passively implement it.
-
How to solve the dilemma of medical standardization? Strengthen the main body of enterprises
Time of Update: 2013-08-30
Zhang Wei said that for a long time, the leading role in the improvement of drug standards in China has been the government departments, while enterprises are unwilling to take the initiative to participate in it, only passively implement it.
-
Financial observation: why does the price of imported drugs stay high
Time of Update: 2013-07-11
Source: Tencent just blew the investigation wind of foreign milk powder enterprises on July 11, 2013, and then went to multinational pharmaceutical enterprises
China's
-
Future market rumors
Time of Update: 2008-11-03
However, a well-informed person said that Friday's sharp drop in prices is likely to be just a quick technical repair process formed by active adjustment of main and multi funds, which is completely normal in bull market.
-
China's accession to WTO and agricultural innovation
Time of Update: 2002-06-04
Introduction: after China's accession to WTO, China's agricultural production, market, trade and management need to be in line with the international standards in a timely manner
-
Entering WTO brings five opportunities for agriculture
Time of Update: 2002-03-21
Introduction: Dr
Sun Dongsheng, director of international agricultural products trade research center of Chinese Academy of Agricultural Sciences, member of agricultural
-
Testing meat processing after entering WTO
Time of Update: 2002-01-24
The majority of meat production in China belongs to the nature of primary processing, with low added value, short preservation and shelf life, and poor market adaptability.
-
China's soybean has great potential in the international market
Time of Update: 2002-01-22
Experts believe that European Union and other soybean consuming countries have doubts and repels on genetically modified crops, which undoubtedly provides a huge potential market space for China's soybean export.
-
China's entry into WTO brings opportunities to soybean export
Time of Update: 2002-01-21
Jbv experts believe that European Union and other soybean consuming countries have doubts and repels on genetically modified crops, which undoubtedly provides a very large potential market space for China's soybean export.